The prevalence of atrial fibrillation in Greenland: a register-based cross-sectional study based on disease classifications and prescriptions of oral anticoagulants

Albertsen, Niels; Riahi, Sam; Pedersen, Marie Louise Mariager; Skovgaard, Nils; Andersen, Stig

doi:10.1080/22423982.2022.2030522

Cited by 11 publications

(35 citation statements)

References 39 publications

(40 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In those age ≥70 years, the prevalence increased to 11.9% (95% CI, 10.3%–13.6%) and 10.1% (95% CI, 8.6%-11.8%), respectively. 50…”

Section: Disorders Of Heart Rhythmmentioning

confidence: 99%

2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association

Martin,

Aday,

Almarzooq

et al. 2024

Circulation

174

View full text Add to dashboard Cite

BACKGROUND: The American Heart Association (AHA), in conjunction with the National Institutes of Health, annually reports the most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health behaviors (smoking, physical activity, nutrition, sleep, and obesity) and health factors (cholesterol, blood pressure, glucose control, and metabolic syndrome) that contribute to cardiovascular health. The AHA Heart Disease and Stroke Statistical Update presents the latest data on a range of major clinical heart and circulatory disease conditions (including stroke, brain health, complications of pregnancy, kidney disease, congenital heart disease, rhythm disorders, sudden cardiac arrest, subclinical atherosclerosis, coronary heart disease, cardiomyopathy, heart failure, valvular disease, venous thromboembolism, and peripheral artery disease) and the associated outcomes (including quality of care, procedures, and economic costs). METHODS: The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing. The 2024 AHA Statistical Update is the product of a full year’s worth of effort in 2023 by dedicated volunteer clinicians and scientists, committed government professionals, and AHA staff members. The AHA strives to further understand and help heal health problems inflicted by structural racism, a public health crisis that can significantly damage physical and mental health and perpetuate disparities in access to health care, education, income, housing, and several other factors vital to healthy lives. This year’s edition includes additional global data, as well as data on the monitoring and benefits of cardiovascular health in the population, with an enhanced focus on health equity across several key domains. RESULTS: Each of the chapters in the Statistical Update focuses on a different topic related to heart disease and stroke statistics. CONCLUSIONS: The Statistical Update represents a critical resource for the lay public, policymakers, media professionals, clinicians, health care administrators, researchers, health advocates, and others seeking the best available data on these factors and conditions.

show abstract

“…In those age ≥70 years, the prevalence increased to 11.9% (95% CI, 10.3%–13.6%) and 10.1% (95% CI, 8.6%-11.8%), respectively. 50…”

Section: Disorders Of Heart Rhythmmentioning

confidence: 99%

2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association

Martin,

Aday,

Almarzooq

et al. 2024

Circulation

174

View full text Add to dashboard Cite

show abstract

“…Furthermore, data show that the rate of revascularization in Greenlandic citizens is as high as in Danish citizens [ 18 ]. A separate register study investigating the prevalence of AF in Greenland revealed that nearly half of the cases did not have a registered diagnosis of AF/AFL [ 36 ]. Consequently, it is plausible to consider that the actual IR of IHD in Greenland may be higher than our findings suggest, potentially due to a significant number of undiagnosed cases.…”

Section: Discussionmentioning

confidence: 99%

“…Evidence of underdiagnosis in Greenland is accumulating. As previously mentioned, the number of unregistered cases of AF/AFL is high, and revascularization rates among Greenlanders are comparable to those of Danes [ 18 , 36 ]. Furthermore, studies indicates that conditions such as osteoporosis and psoriasis are underdiagnosed in the population [ 54 , 55 ].…”

Section: Discussionmentioning

confidence: 99%

Trends in cardiovascular disease among Inuit in Greenland from 1994 to 2021

Larsen,

Geisler,

Gustafsson

et al. 2024

Atherosclerosis Plus

View full text Add to dashboard Cite

“…For some conditions/diagnoses, prescription data can be used as a proxy. 34 , 35 Therefore, the Danish National Prescription Registry was also identified as a data source of Diagnosis. Non-clinical outcomes were only used in 12% (n = 25) of the studies with coupling to 17% (n = 12) of the exposure groups and 30% (n = 13) of the registries.…”

Section: Discussionmentioning

confidence: 99%

Mapping Outcomes and Registries Used in Current Danish Pharmacoepidemiological Research

Petersen¹,

Jensen²,

Rosenzweig³

et al. 2022

CLEP

View full text Add to dashboard Cite

Purpose There is an increasing need for national and international pharmacoepidemiological studies based on high-quality real-world data of which the Danish registries are a valuable source. In lack of a complete overview of which data are used to assess real-world drug safety and effectiveness outcomes, we aimed to map the outcomes, data sources, and the reporting of outcome quality in recent pharmacoepidemiological studies. Methods We conducted a systematic mapping review of pharmacoepidemiological studies based on Danish registries investigating drug safety and/or effectiveness, published in the period 2018–2019, identified in PubMed and Scopus. Extraction included: Anatomical Therapeutic Chemical level 2 code for drug exposures, outcomes, outcome data sources, and quality of outcomes. Results Of the 210 included studies, 96% used outcomes categorized as Clinical, 4% utilized outcomes categorized as Society-related, 5% used outcomes categorized as Healthcare cost and utilization, and 3% of the studies applied outcomes categorized as Patient-reported in which the percentages are not mutually exclusive. Diagnosis (66%) and Mortality (38%) were the two most utilized subcategories among those categorized as Clinical outcomes. Danish Health Data Authority and Statistics Denmark registries were the most reported outcome data sources (90%). Ninety-six studies (46%) reported one or more quality parameters related to their outcomes of interest with accuracy/validity being the most reported parameter (22%). Conclusion The Danish registries support a wide range of outcomes. Across therapeutic areas, most studies investigate traditional clinical outcomes of disease and mortality based on data from a small number of available registries. In contrast, clinical and biochemical databases, despite potentially offering outcomes with high responsiveness, and the high-quality social and healthcare cost registries were rarely used as outcome data sources.

show abstract

The prevalence of atrial fibrillation in Greenland: a register-based cross-sectional study based on disease classifications and prescriptions of oral anticoagulants

Cited by 11 publications

References 39 publications

2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association

2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association

Trends in cardiovascular disease among Inuit in Greenland from 1994 to 2021

Mapping Outcomes and Registries Used in Current Danish Pharmacoepidemiological Research

Contact Info

Product

Resources

About